|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1997-3-11
|
|
pubmed:abstractText |
The Australian Collaborative Trial of Antenatal Thyrotropin-Releasing Hormone (ACTOBAT) assessed the efficacy of 200 microg of thyrotropin-releasing hormone (TRH) in combination with glucocorticoids in the prevention of neonatal lung disease. This paper reports the 12-month follow-up of the infants from the trial completed in 1994.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1098-4275
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
99
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
311-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9041281-Adult,
pubmed-meshheading:9041281-Developmental Disabilities,
pubmed-meshheading:9041281-Drug Therapy, Combination,
pubmed-meshheading:9041281-Female,
pubmed-meshheading:9041281-Follow-Up Studies,
pubmed-meshheading:9041281-Glucocorticoids,
pubmed-meshheading:9041281-Humans,
pubmed-meshheading:9041281-Infant, Newborn,
pubmed-meshheading:9041281-Infant Mortality,
pubmed-meshheading:9041281-Logistic Models,
pubmed-meshheading:9041281-Male,
pubmed-meshheading:9041281-Obstetric Labor, Premature,
pubmed-meshheading:9041281-Pregnancy,
pubmed-meshheading:9041281-Prenatal Care,
pubmed-meshheading:9041281-Respiratory Distress Syndrome, Newborn,
pubmed-meshheading:9041281-Thyrotropin-Releasing Hormone
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Australian Collaborative Trial of Antenatal Thyrotropin-Releasing Hormone: adverse effects at 12-month follow-up. ACTOBAT Study Group.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynaecology, University of Adelaide, South Australia.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comment,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
